A synthetic peptide for use as a blocking control in assays to test for specificity of CA5 A antibody, Alternative Names: CA5A control peptide, CA5A antibody Blocking Peptide, Anti-CA5A Blocking Peptide, carbonic anhydrase VA, mitochondrial Blocking Peptide, CA5 Blocking Peptide, CAV Blocking Peptide, CAVA Blocking Peptide, CA5A, CAA-5, CAA 5, CAA-5 Blocking Peptide, CAA 5 Blocking Peptide
CA5A
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CA5A
(Carbonic Anhydrase VA (CA5A))
Hintergrund
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA VA is localized in the mitochondria and expressed primarily in the liver. It may play an important role in ureagenesis and gluconeogenesis. CA5A gene maps to chromosome 16q24.3 and an unprocessed pseudogene has been assigned to 16p12-p11.2.